Korean J Sports Med.  2024 Mar;42(1):46-54. 10.5763/kjsm.2024.42.1.46.

Association of Changes in Sitting Time with the Risk of Developing Diabetes: A Community-Based Cohort Study

• Park D
• Kim YS
• Kim E

• KMID: 2553556
• DOI: http://doi.org/10.5763/kjsm.2024.42.1.46

Abstract

Purpose
The purpose of the present study was to investigate the relationship between changes in sitting time (ST) with the risk of developing metabolic syndrome.
Methods
This study examined 2,814 adults aged 40 to 69 years who participated in the Korean Genome and Epidemiology Study, a community-based cohort study, for a total of 10 years. Changes in ST were assessed using the results obtained from physical activity questionnaires completed during the baseline and follow-up surveys. The diagnosis of metabolic syndrome was classified according to the criteria established by the International Diabetes Federation. We conducted survival analysis by the multivariate extended Cox regression model. The significance level for all analyses was set at p＜ 0.05.
Results
We compared the newly ST group with ST less than 7 hours in the baseline and more than 7 hours in the first follow-up to the consistently non-ST group with ST less than 7 hours in both the baseline and the first follow-up. In this comparison, we found that the hazard ratio (HR) for the incidence of metabolic syndrome increased by 33% (HR, 1.33; 95% confidence interval [CI], 1.02–1.74) for changes in total daily sedentary time and by 47% (HR, 1.47; 95% CI, 1.13–1.92) for changes in weekday sedentary time in the newly ST group.
Conclusion
Changes in ST are associated with the risk of developing metabolic syndrome. These findings can serve as fundamental data for further research on the relationship between changes in ST, and the occurrence of metabolic syndrome.

Keyword

Sedentary behavior; Aged; Metabolic syndrome; Proportional hazards models; Cohort studies

Reference

1. O'Neill S, O'Driscoll L. 2015; Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 16:1–12. DOI: 10.1111/obr.12229. PMID: 25407540.

2. Isomaa B, Almgren P, Tuomi T, et al. 2001; Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:683–9. DOI: 10.2337/diacare.24.4.683. PMID: 11315831.

3. Liang X, Or B, Tsoi MF, Cheung CL, Cheung BM. 2023; Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011-18. Postgrad Med J. 99:985–92. DOI: 10.1093/postmj/qgad008. PMID: 36906842.

4. Kim SM, Kang DT. 2021 Health insurance statistical yearbook. Health Insurance Review and Assessment Service, National Health Insurance Service (Korea);2022.

5. Fahed G, Aoun L, Bou Zerdan M, et al. 2022; Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 23:786. DOI: 10.3390/ijms23020786. PMID: 35054972. PMCID: PMC8775991.

6. Grundy SM, Cleeman JI, Daniels SR, et al. 2005; Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 112:2735–52. DOI: 10.1161/CIRCULATIONAHA.105.169404. PMID: 16157765.

7. Yeo Y, Cho IY, Sim MS, Song HG, Song YM. 2021; Relationship between daily sedentary behaviors and metabolic syndrome in middle-aged adults: results from a health survey in Taean-Gun, Republic of Korea. Metab Syndr Relat Disord. 19:48–55. DOI: 10.1089/met.2020.0021. PMID: 33121386.

8. Tremblay MS, Colley RC, Saunders TJ, Healy GN, Owen N. 2010; Physiological and health implications of a sedentary lifestyle. Appl Physiol Nutr Metab. 35:725–40. DOI: 10.1139/H10-079. PMID: 21164543.

9. Katzmarzyk PT, Powell KE, Jakicic JM, et al. 2019; Sedentary behavior and health: update from the 2018 Physical Activity Guidelines Advisory Committee. Med Sci Sports Exerc. 51:1227–41. DOI: 10.1249/MSS.0000000000001935. PMID: 31095080. PMCID: PMC6527341.

10. Garthwaite T, Sjöros T, Laine S, et al. 2022; Effects of reduced sedentary time on cardiometabolic health in adults with metabolic syndrome: a three-month randomized controlled trial. J Sci Med Sport. 25:579–85. DOI: 10.1016/j.jsams.2022.04.002. PMID: 35487860.

11. Alberti KG, Eckel RH, Grundy SM, et al. 2009; Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120:1640–5. DOI: 10.1161/CIRCULATIONAHA.109.192644. PMID: 19805654.

12. Cabanas-Sánchez V, Guallar-Castillón P, Higueras-Fresnillo S, Rodríguez-Artalejo F, Martínez-Gómez D. 2018; Changes in sitting time and cardiovascular mortality in older adults. Am J Prev Med. 54:419–22. DOI: 10.1016/j.amepre.2017.10.010.

13. Bowlby W, Zelnick LR, Henry C, et al. 2016; Physical activity and metabolic health in chronic kidney disease: a cross-sectional study. BMC Nephrol. 17:187. DOI: 10.1186/s12882-016-0400-x. PMID: 27876008. PMCID: PMC5120456.

14. Parker K, Tucker LA. 2021; The role of physical activity in the relationship between sitting time and insulin resistance. Int J Exerc Sci Conf Proc. 14:47.

15. International Physical Activity Questionnaire (IPAQ) Research Committee. 2005. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ): short and long forms [Internet]. IPAQ;Available from: https://www.researchgate.net/file.PostFileLoader.html?id=5641f4c36143250eac8b45b7&assetKey=AS%3A294237418606593%401447163075131. cited 2023 Dec 13.

16. Baik SH, Fung KW, McDonald CJ. 2022; The mortality risk of proton pump inhibitors in 1.9 million US seniors: an extended cox survival analysis. Clin Gastroenterol Hepatol. 20:e671–81. DOI: 10.1016/j.cgh.2021.01.014. PMID: 33453399.

17. Macías N, Espinosa-Montero J, Monterrubio-Flores E, et al. 2021; Screen-based sedentary behaviors and their association with metabolic syndrome components among adults in Mexico. Prev Chronic Dis. 18:E95. DOI: 10.5888/pcd18.210041. PMID: 34735313. PMCID: PMC8588869.

18. Gennuso KP, Gangnon RE, Thraen-Borowski KM, Colbert LH. 2015; Dose-response relationships between sedentary behaviour and the metabolic syndrome and its components. Diabetologia. 58:485–92. DOI: 10.1007/s00125-014-3453-z. PMID: 25476524.

19. Pedisic Z, Grunseit A, Ding D, et al. 2014; High sitting time or obesity: which came first? Bidirectional association in a longitudinal study of 31,787 Australian adults. Obesity (Silver Spring). 22:2126–30. DOI: 10.1002/oby.20817. PMID: 24943057. PMCID: PMC4265269.

20. Grunseit AC, Chau JY, Rangul V, Holmen TL, Bauman A. 2017; Patterns of sitting and mortality in the Nord-Trøndelag health study (HUNT). Int J Behav Nutr Phys Act. 14:8. DOI: 10.1186/s12966-016-0457-8. PMID: 28122625. PMCID: PMC5267382.

21. Matthews CE, George SM, Moore SC, et al. 2012; Amount of time spent in sedentary behaviors and cause-specific mortality in US adults. Am J Clin Nutr. 95:437–45. DOI: 10.3945/ajcn.111.019620. PMID: 22218159. PMCID: PMC3260070.

22. Hamilton MT, Hamilton DG, Zderic TW. 2014; Sedentary behavior as a mediator of type 2 diabetes. Med Sport Sci. 60:11–26. DOI: 10.1159/000357332. PMID: 25226797. PMCID: PMC4364419.

23. Sena CM, Pereira AM, Seiça R. 2013; Endothelial dysfunction: a major mediator of diabetic vascular disease. Biochim Biophys Acta. 1832:2216–31. DOI: 10.1016/j.bbadis.2013.08.006. PMID: 23994612.

24. Hamilton MT, Hamilton DG, Zderic TW. 2007; Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes. 56:2655–67. DOI: 10.2337/db07-0882. PMID: 17827399.

25. Craig CL, Marshall AL, Sjöström M, et al. 2003; International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 35:1381–95. DOI: 10.1249/01.MSS.0000078924.61453.FB. PMID: 12900694.

26. Marshall S, Kerr J, Carlson J, et al. 2015; Patterns of weekday and weekend sedentary behavior among older adults. J Aging Phys Act. 23:534–41. DOI: 10.1123/japa.2013-0208. PMID: 25415205. PMCID: PMC4447597.

27. Boden G, Shulman GI. 2002; Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and bseta-cell dysfunction. Eur J Clin Invest. 32 Suppl 3:14–23. DOI: 10.1046/j.1365-2362.32.s3.3.x. PMID: 12028371.

28. Griffin ME, Marcucci MJ, Cline GW, et al. 1999; Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48:1270–4. DOI: 10.2337/diabetes.48.6.1270. PMID: 10342815.